News
-
-
-
-
PRESS RELEASE
Press Release: Sanofi’s Qfitlia and Cablivi approved in China, expanding care for rare diseases
Sanofi's Qfitlia and Cablivi have been approved in China by the National Medical Products Administration, expanding care for rare diseases in the country. Qfitlia offers protection for hemophilia with as few as six injections a year, while Cablivi targets a rare life-threatening blood clotting disorder -
PRESS RELEASE
PURE Swiss Opportunity REF (PSO) – successful completion of the significantly oversubscribed capital increase
PURE Swiss Opportunity REF (PSO) successfully completed a significantly oversubscribed CHF 40 Mio. capital increase, with 306,384 newly issued units and a total of 1,685,114 outstanding units -
PRESS RELEASE
Intrusion Launches Shield Stratus: Cloud-Native Packet Filtering That Doesn't Play Nice With Bad Traffic
Intrusion Inc. releases Shield Stratus, a cloud-native packet filtering solution providing full-fidelity visibility and reputation-based blocking for cloud workloads. The solution integrates seamlessly with AWS Gateway Load Balancer, ensuring 100% traffic inspection and immediate threat blocking -
PRESS RELEASE
Lir Life Sciences Completes Design of a Comparative Animal Study Investigating Cell-Penetrating Peptide-Mediated Delivery of GLP/GIP-Based Obesity Therapies
Lir Life Sciences Corp. announces a new comparative cell-penetrating peptide-based uptake study for GLP/GIP-based obesity therapies, enhancing transdermal delivery options. The study aims to improve treatment adherence and effectiveness for metabolic conditions -
-
-
PRESS RELEASE
TenX Protocols, a DeFi Technologies Advisory Client and Venture Investment, Debuts on TSX Venture Exchange as "TNX" Following Successful $30 Million Financing
DeFi Technologies' client TenX Protocols debuts on TSX Venture Exchange as 'TNX' following $30M financing, attracting leading investors
